Lung Cancer Therapeutics Market Trends, Growth, Opportunities, Analysis and Forecast to 2030 | MRFR
Lung Cancer Therapeutics Market Lung Cancer Therapeutics Market is expected to reach value of USD 30.5 Billion by 2030 at 9.11% CAGR during the forecast period 2022-2030. Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in lung tissue with symptoms such as coughing, weight loss, and fatigue and chest pain. The two types of lung cancers are small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC). The NSCLC type accounts for almost 80% of the total lung cancers. The cure rates for the two types of lung cancers exchange their positions with the SCLC being the most malignant. The cure rates also depend on the stage of cancer detection with rates varying by 55% for first stage to just 1% for stage four Almost 85% of cases of lung cancer are due to long-term tobacco smoking. Cigarette smoke contains at least 73 known carcinogens. Other factors causing lung cancer are genetic factors and exposure to triggers and carcinogens such as radon ga...